Regulating Intermediate Technologies

Rachel E. Sachs

Yale Journal on Regulation2020article
ABDC B
Weight
0.26

What the paper says

Over the last several years, scholars studying health innovation policy have carefully considered the ways in which policymakers regulate different types of technologies to encourage their development and dissemination. Scholars have examined a range of legal incentives, including patents, Food and Drug Administration (FDA) exclusivity periods, taxes, grants, insurance reimbursement, and other tools to promote socially valuable innovations that our current system has structurally disfavored.

Cite this paper

@article{rachel2020,
  title        = {{Regulating Intermediate Technologies}},
  author       = {Rachel E. Sachs},
  journal      = {Yale Journal on Regulation},
  year         = {2020},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Regulating Intermediate Technologies

Flags are reviewed by the Arbiter methodology team within 5 business days.


Evidence weight

0.26

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.00 × 0.4 = 0.00
M · momentum0.20 × 0.15 = 0.03
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.